Nabi Biopharmaceuticals Completes Enrollment of Second NicVAX Phase III Clinical Trial
09. November 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine...
Nabi Biopharmaceuticals Announces Third Quarter 2010 Financial Results
03. November 2010 16:01 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 3, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the quarter ended September 25, 2010. The Company...
Nabi Biopharmaceuticals Announces Third Quarter 2010 Financial Results Release Date
26. Oktober 2010 10:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 26, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) will report its third quarter 2010 financial results on Wednesday, November 3, 2010, after the market close. The...
Nabi Biopharmaceuticals to Present at Rodman & Renshaw's Annual Global Investment Conference
07. September 2010 11:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at the Rodman &...
Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
01. September 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc....
Nabi Biopharmaceuticals Significantly Enhances NicVAX Patent Portfolio
24. August 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 24, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related...
Nabi Biopharmaceuticals Completes Third PentaStaph(TM) Milestone
10. August 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 10, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has successfully completed the technology transfer of program know-how associated with...
Nabi Biopharmaceuticals Announces Second Quarter 2010 Financial Results
05. August 2010 16:02 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 26, 2010. The Company...
Nabi Biopharmaceuticals Announces Second Quarter 2010 Financial Results Release Date
26. Juli 2010 10:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 26, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) will report its second quarter 2010 financial results on Thursday, August 5, 2010, after the market close. The...
Nabi Biopharmaceuticals Completes Enrollment of First NicVAX Phase III Clinical Trial
14. Juli 2010 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 14, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has completed enrollment in the first Phase III clinical trial of NicVAX® (Nicotine...